1st FDA-Approved Cancer Vaccine
Airtime: Thurs. Apr. 29 2010 | 2:45 PM ET
Shares of Dendreon sharply higher today, with CNBC’s Bertha Coombs.
Similar Posts
Insight from Pimco's Mohamed El-Erian
Insight from Pimco’s Mohamed El-Erian
Econ Analysis: Durable Goods, Jobless Claims 2.25.10
Durable goods rose more than expected, up 3%, and jobless claims rose by 22,000 to 496,000.
March in Like a Bull
The February rally is continuing into March, but how far will it go? Robert Doll, of BlackRock, and Richard LeFrak, of the LeFrak Organization, share their insight.
Nasdaq May Spiral Into a Freefall: Guppy
The Nasdaq could spiral into a freefall if it breaks below the 2,100 point level, warns Daryl Guppy, CEO of Guppytraders.com. He explains why to Howard Eisen, MD & co-founder of FletcherBennett, CNBC’s Martin Soong & Sri Jegarajah.
Trader Talk With Art Cashin 3.26.10
Art Cashin, head of floor operations at UBS, has the buzz from the NYSE.
Steve Wynn on EBITDA
Finally, as he waits for a meaningful Vegas turnaround, Steve Wynn pokes fun at the measurements some analysts and executives use to gauge a company’s success—in short, he mocks EBITDA. “As if depreciation doesn’t exist.”
